NIH-funded research U01 cooperative agreement

Cedars-Sinai Center leads research on chronic pancreatitis and pancreatic cancer

Official title: Cedars Sinai Center for the Chronic Pancreatitis Clinical Research Consortium

Funded at Cedars-Sinai Medical Center · NIH-11401819 · Data updated 2026-11-12

A Cedars-Sinai research center is renewing its program to study chronic pancreatitis, diabetes-related pancreatic disease, and pancreatic cancer so doctors can better understand and treat these conditions.

More Pancreatitis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 28, 2015
Project endJune 30, 2030
Funding year2026
Award (this year)$554,442
NIH project number5U01DK108314-12
Project IDNIH-11401819 on NIH RePORTER

Who could benefit from this research

Could help

Adults and children with chronic pancreatitis, diabetes-related pancreatic conditions, or associated pancreatic cancers who may enroll in cohort studies or ancillary research.

Less likely to help

Some patients may not directly participate in trials or may not experience immediate benefits from ancillary studies.

What this research studies

This grant supports the Cedars-Sinai Clinical Center’s role in coordinating a national consortium focused on pancreatic diseases, including chronic pancreatitis, diabetes-related pancreatic issues, and pancreatic cancer. Researchers will continue recruiting and retaining participants in cohort studies and conducting ancillary studies to uncover how these diseases develop and respond to treatments. The effort combines epidemiology, genetics, biomarkers, and early-diagnosis work to guide future clinical trials and improve patient care. The program also emphasizes collaboration, data sharing, and advancing knowledge that could lead to earlier detection and more effective therapies for patients with pancreatic disorders.

Why it matters

Potential benefit: If successful, patients could benefit from earlier diagnosis, better understanding of disease risk, and more effective, targeted treatments for chronic pancreatitis and pancreatic cancer.

How similar studies have gone: Prior CPCRC-related work has improved recruitment and yielded important epidemiologic, genetic, and biomarker insights; the approach is ongoing and builds on prior successes.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Pandol, Stephen J. — Cedars-Sinai Medical Center
  • Study coordinator: Pandol, Stephen J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.